Table 2.
Group | Preoperative ASIA | Final Follow-Up ASIA | |||||
---|---|---|---|---|---|---|---|
B | C | D | B | C | D | E | |
3DP-AVB (n=12) | 1 | 6 | 5 | 1 | 1 | 3 | 7* |
TMC (n=16) | 2 | 7 | 7 | 1 | 1 | 2 | 12* |
Χ2 | 0.176 | 0.964 | |||||
P | 0.916 | 0.810 |
Note: *P<0.05 Compare with preoperative and final follow-up.
Group | Preoperative ASIA | Final Follow-Up ASIA | |||||
---|---|---|---|---|---|---|---|
B | C | D | B | C | D | E | |
3DP-AVB (n=12) | 1 | 6 | 5 | 1 | 1 | 3 | 7* |
TMC (n=16) | 2 | 7 | 7 | 1 | 1 | 2 | 12* |
Χ2 | 0.176 | 0.964 | |||||
P | 0.916 | 0.810 |
Note: *P<0.05 Compare with preoperative and final follow-up.